Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Vertebral Fracture Risk Using VFA and Vertebral Strength Assessment With DXA-Finite Element Analysis in Liver Transplant Recipients in Pretransplant Period

NCT03811873 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03811873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03811873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Vertebral Fracture Risk Using VFA and Vertebral Strength Assessment With DXA-Finite Element Analysis in Liver Transplant Recipients in Pretransplant Period
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
February 18, 2019
Completion date
August 30, 2022
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic bone disease, secondary osteoporosis, transplant-related disorder